| Measure Type | High Priority Measure? | Collection Type(s) |
|---|---|---|
| Process | no | MIPS CQM |
Measure Description
If a patient has been newly prescribed a biologic disease-modifying anti-rheumatic drug (DMARD) therapy, then the medical record should indicate TB testing in the preceding 12-month period.